These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35717581)

  • 1. [Proteolysis and deficiency of α1-proteinase inhibitor in SARS-CoV-2 infection].
    Akbasheva OE; Spirina LV; Dyakov DA; Masunova NV
    Biomed Khim; 2022 Jun; 68(3):157-176. PubMed ID: 35717581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection.
    Akbasheva OE; Spirina LV; Dyakov DA; Masunova NV
    Biochem Mosc Suppl B Biomed Chem; 2022; 16(4):271-291. PubMed ID: 36407837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
    Gkogkou E; Barnasas G; Vougas K; Trougakos IP
    Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
    Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
    J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d-Galactose treatment increases ACE2, TMPRSS2, and FURIN and reduces SERPINA1 mRNA expression in A549 human lung epithelial cells.
    Baristaite G; Gurwitz D
    Drug Dev Res; 2022 May; 83(3):622-627. PubMed ID: 34677831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-2 macroglobulin activity in SARS-CoV-2 induced infection and in the post-COVID-19 period.
    Akbasheva OE; Mitrofanova DK; Spirina LV; Samoilova YG; Matveeva MV; Podchinenova DV; Oleynik OA
    Biomed Khim; 2023 Sep; 69(4):240-247. PubMed ID: 37705485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?
    Yamamoto N; Yamamoto R; Ariumi Y; Mizokami M; Shimotohno K; Yoshikura H
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
    Xiao L; Sakagami H; Miwa N
    Viruses; 2020 Apr; 12(5):. PubMed ID: 32354022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion.
    Kaur U; Chakrabarti SS; Ojha B; Pathak BK; Singh A; Saso L; Chakrabarti S
    Curr Drug Targets; 2021; 22(2):192-201. PubMed ID: 32972339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basis of complications in the context of SARS-CoV-2 infection: Pathological activation of ADAM17.
    Jiang S; Yang H; Sun Z; Zhang Y; Li Y; Li J
    Biochem Biophys Res Commun; 2023 Oct; 679():37-46. PubMed ID: 37666046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Proteases for Treating COVID-19.
    Luan B; Huynh T; Cheng X; Lan G; Wang HR
    J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
    Drak Alsibai K
    Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the pathogenesis of the adult respiratory distress syndrome.
    McGuire WW; Spragg RG; Cohen AB; Cochrane CG
    J Clin Invest; 1982 Mar; 69(3):543-53. PubMed ID: 7037851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later.
    Angeli F; Zappa M; Reboldi G; Trapasso M; Cavallini C; Spanevello A; Verdecchia P
    Eur J Intern Med; 2021 Nov; 93():28-34. PubMed ID: 34588140
    [No Abstract]   [Full Text] [Related]  

  • 20. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
    Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.